Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

Vectormune ND : EPAR - Summary for the public

български (BG) (93.36 KB - PDF)
español (ES) (81.97 KB - PDF)
čeština (CS) (93.99 KB - PDF)
dansk (DA) (83.34 KB - PDF)
Deutsch (DE) (82.76 KB - PDF)
eesti keel (ET) (82.18 KB - PDF)
ελληνικά (EL) (93.76 KB - PDF)
français (FR) (82.44 KB - PDF)
hrvatski (HR) (92.27 KB - PDF)
íslenska (IS) (83.29 KB - PDF)
Gaeilge (GA) (83.57 KB - PDF)
italiano (IT) (82.29 KB - PDF)
latviešu valoda (LV) (94.29 KB - PDF)
lietuvių kalba (LT) (94.03 KB - PDF)
magyar (HU) (94.15 KB - PDF)
Malti (MT) (95.95 KB - PDF)
Nederlands (NL) (82.05 KB - PDF)
norsk (NO) (82 KB - PDF)
polski (PL) (95.62 KB - PDF)
português (PT) (83.01 KB - PDF)
română (RO) (94.17 KB - PDF)
slovenčina (SK) (94.08 KB - PDF)
slovenščina (SL) (82.27 KB - PDF)
Suomi (FI) (81.54 KB - PDF)
svenska (SV) (82.05 KB - PDF)

Product information

Vectormune ND : EPAR - Product Information

български (BG) (91.78 KB - PDF)
español (ES) (81.51 KB - PDF)
čeština (CS) (92.48 KB - PDF)
dansk (DA) (82.05 KB - PDF)
Deutsch (DE) (81.72 KB - PDF)
eesti keel (ET) (81.22 KB - PDF)
ελληνικά (EL) (91.79 KB - PDF)
français (FR) (81.63 KB - PDF)
hrvatski (HR) (91.56 KB - PDF)
íslenska (IS) (81.52 KB - PDF)
Gaeilge (GA) (81.36 KB - PDF)
italiano (IT) (81.76 KB - PDF)
latviešu valoda (LV) (92.14 KB - PDF)
lietuvių kalba (LT) (92.19 KB - PDF)
magyar (HU) (92.76 KB - PDF)
Malti (MT) (93.86 KB - PDF)
Nederlands (NL) (81.15 KB - PDF)
norsk (NO) (81.52 KB - PDF)
polski (PL) (93.22 KB - PDF)
português (PT) (82.53 KB - PDF)
română (RO) (91.73 KB - PDF)
slovenčina (SK) (81.75 KB - PDF)
slovenščina (SL) (81.76 KB - PDF)
Suomi (FI) (81.11 KB - PDF)
svenska (SV) (81.47 KB - PDF)

Vectormune ND : EPAR - All Authorised presentations

български (BG) (93.36 KB - PDF)
español (ES) (81.97 KB - PDF)
čeština (CS) (93.99 KB - PDF)
dansk (DA) (83.34 KB - PDF)
Deutsch (DE) (82.76 KB - PDF)
eesti keel (ET) (82.18 KB - PDF)
ελληνικά (EL) (93.76 KB - PDF)
français (FR) (82.44 KB - PDF)
hrvatski (HR) (92.27 KB - PDF)
íslenska (IS) (83.29 KB - PDF)
Gaeilge (GA) (83.57 KB - PDF)
italiano (IT) (82.29 KB - PDF)
latviešu valoda (LV) (94.29 KB - PDF)
lietuvių kalba (LT) (94.03 KB - PDF)
magyar (HU) (94.15 KB - PDF)
Malti (MT) (95.95 KB - PDF)
Nederlands (NL) (82.05 KB - PDF)
norsk (NO) (82 KB - PDF)
polski (PL) (95.62 KB - PDF)
português (PT) (83.01 KB - PDF)
română (RO) (94.17 KB - PDF)
slovenčina (SK) (94.08 KB - PDF)
slovenščina (SL) (82.27 KB - PDF)
Suomi (FI) (81.54 KB - PDF)
svenska (SV) (82.05 KB - PDF)

Product details

Name of medicine
Vectormune ND
International non-proprietary name (INN) or common name
Newcastle disease and Marek’s disease vaccine (live recombinant)

Pharmacotherapeutic group

  • Immunologicals for aves
  • Live viral vaccines

Authorisation details

EMA product number
EMEA/V/C/003829

Assessment history

Vectormune ND : EPAR - Procedural steps taken and scientific information after authorisation

Vectormune ND-V-C-003829-II-0007 : EPAR - Assessment Report - Variation

CVMP post-authorisation summary of positive opinion for Vectormune ND (II/0007)

Vectormune ND : EPAR - Public assessment report

CVMP summary of positive opinion for Vectormune ND

This page was last updated on

How useful do you find this page?